Miret Noelia V, Pontillo Carolina A, Buján Sol, Chiappini Florencia A, Randi Andrea S
Universidad de Buenos Aires, Facultad de Medicina, Departamento de Bioquímica Humana, Laboratorio de Efectos Biológicos de Contaminantes Ambientales, Paraguay 2155, Piso 5, (CP 1121), Buenos Aires, Argentina; Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Físico-Matemática, Laboratorio de Radioisótopos, Junín 954, 1er subsuelo (CP1113), Buenos Aires, Argentina.
Universidad de Buenos Aires, Facultad de Medicina, Departamento de Bioquímica Humana, Laboratorio de Efectos Biológicos de Contaminantes Ambientales, Paraguay 2155, Piso 5, (CP 1121), Buenos Aires, Argentina.
Biochem Pharmacol. 2023 Oct;216:115773. doi: 10.1016/j.bcp.2023.115773. Epub 2023 Sep 1.
Breast cancer is the most common invasive malignancy among women worldwide and constitutes a complex and heterogeneous disease. Interest has recently grown in the role of the aryl hydrocarbon receptor (AhR) in breast cancer and the contribution of environment-polluting AhR agonists. Here, we present a literature review addressing AhR ligands, including pesticides hexachlorobenzene and chlorpyrifos, polycyclic aromatic hydrocarbons, polychlorinated dibenzo-p-dioxins and dibenzofurans, polychlorinated biphenyls, parabens, and phthalates. The objectives of this review are a) to summarize recent original experimental, preclinical, and clinical studies on the biological mechanisms of AhR agonists which interfere with the regulation of breast endocrine functions, and b) to examine the biological effects of AhR ligands and their impact on breast cancer development and progression. We discuss biological mechanisms of action in cell viability, cell cycle, proliferation, epigenetic changes, epithelial to mesenchymal transition, and cell migration and invasion. In addition, we examine the effects of AhR ligands on angiogenic processes, metastasis, chemoresistance, and stem cell renewal. We conclude that exposure to AhR agonists stimulates pathways that promote breast cancer development and may contribute to tumor progression. Given the massive use of industrial and agricultural chemicals, ongoing evaluation of their effects in laboratory assays and preclinical studies in breast cancer at environmentally relevant doses is deemed essential. Likewise, awareness should be raised in the population regarding the most harmful toxicants to eradicate or minimize their use.
乳腺癌是全球女性中最常见的侵袭性恶性肿瘤,是一种复杂的异质性疾病。近年来,芳烃受体(AhR)在乳腺癌中的作用以及环境污染物AhR激动剂的影响受到了越来越多的关注。在此,我们对AhR配体进行文献综述,包括农药六氯苯和毒死蜱、多环芳烃、多氯二苯并对二恶英和二苯并呋喃、多氯联苯、对羟基苯甲酸酯和邻苯二甲酸盐。本综述的目的是:a)总结近期关于AhR激动剂干扰乳腺内分泌功能调节的生物学机制的原始实验、临床前和临床研究;b)研究AhR配体的生物学效应及其对乳腺癌发生和发展的影响。我们讨论了AhR激动剂在细胞活力、细胞周期、增殖、表观遗传变化、上皮-间质转化以及细胞迁移和侵袭等方面的生物学作用机制。此外,我们还研究了AhR配体对血管生成过程、转移、化疗耐药性和干细胞更新的影响。我们得出结论,接触AhR激动剂会刺激促进乳腺癌发展的途径,并可能导致肿瘤进展。鉴于工农业化学品的大量使用,在实验室检测和乳腺癌临床前研究中,以环境相关剂量持续评估其影响被认为至关重要。同样,应提高公众对最有害毒物的认识,以根除或尽量减少其使用。